Beckman Coulter, Inc. provides biomedical testing instrument systems, tests, and supplies for clinical laboratories worldwide. The company offers chemistry systems, such as routine chemistry systems that use electrochemical detection, chemical reactions with patient samples, and antigen-antibody reactions to detect and quantify substances of diagnostic interest in blood, urine, and other body fluids; point of care testing products comprising rapid diagnostic test kits and hematology instruments that give physicians information to manage patient treatment; and manual and automated electrophoresis products. It also provides immunoassay systems performing tests that assess thyroid function, screen and monitor for cancer and cardiac risk, provide information in fertility and reproductive testing, and monitor factors associated with anemia, blood viruses, infectious disease, and therapeutic drugs. In addition, the company offers cellular systems for clinicians, such as hematology systems to study formed elements in blood, such as red and white blood cells and platelets; hemostasis systems offering information to diagnose bleeding and clotting disorders and to monitor anticoagulant therapy; and flow cytometry systems used in applications in basic research, clinical research, and drug discovery. Its discovery and automation products include clinical laboratory automation systems, life sciences automation products, biomarker discovery, genetic analysis systems, centrifugation, particle characterization, life sciences tools, and molecular diagnostics. The company’s products are used in various applications ranging from lab solutions used for medical research, clinical research, and drug discovery to diagnostic systems in hospitals and physicians’ offices to aid in patient care. The company was founded in 1934. It was formerly known as Beckman Instruments, Inc. and changed its name to Beckman Coulter, Inc. in 1998. Beckman Coulter is headquartered in Fullerton, California.